{"id":936857,"date":"2026-02-12T20:00:44","date_gmt":"2026-02-13T01:00:44","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/mdxhealth-to-present-fourth-quarter-and-full-year-2025-financial-results-and-corporate-update-on-february-26\/"},"modified":"2026-02-12T20:00:44","modified_gmt":"2026-02-13T01:00:44","slug":"mdxhealth-to-present-fourth-quarter-and-full-year-2025-financial-results-and-corporate-update-on-february-26","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/mdxhealth-to-present-fourth-quarter-and-full-year-2025-financial-results-and-corporate-update-on-february-26\/","title":{"rendered":"Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26"},"content":{"rendered":"
\n

\n Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results<\/b>
\n and Corporate Update on February 26<\/b>\n <\/p>\n

\n
\n Company to Host Conference Call with Live Q&A, February 26, 2026, at 4:30pm ET \/ 22:30 CET<\/i>
\n <\/b>\n <\/p>\n

\n IRVINE, California <\/b>\u2013 February 12, 2026 (GlobeNewswire<\/a>) \u2013 MDxHealth SA (NASDAQ: MDXH), a leading precision diagnostics company, today announced it will release its financial results for the fourth quarter and full year ended December 31, 2025, after market close on Thursday, February 26, 2026.<\/p>\n\n\n\n\n\n\n\n
\n Title:<\/b><\/p>\n<\/td>\nMdxhealth Presents Fourth Quarter and Full Year 2025 Financial Results and
Corporate Update Conference Call and Webcast<\/td>\n<\/tr>\n
\n Date:<\/b>\n <\/td>\nFebruary 26, 2026<\/td>\n<\/tr>\n
\n Time:<\/b>\n <\/td>\n4:30pm ET\/ 22:30 CET<\/td>\n<\/tr>\n
\n Conference Call D<\/b>
\n ial-in <\/b>
\n Details:<\/b>\n <\/td>\n		\n

United States<\/b>: 1-844-825-9789
Int\u2019l: <\/b>1-412-317-5180
Belgium<\/b>: 0800 38 961
United Kingdom<\/b>: 0800 279 9489<\/p>\n<\/td>\n<\/tr>\n

\n Conference ID:<\/b>\n <\/td>\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 10206764<\/td>\n<\/tr>\n
\n Webcast:<\/b>\n <\/td>\n\n https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1753070&tp_key=27bce7d4de<\/a>\n <\/td>\n<\/tr>\n<\/table>\n

The webcast should be accessed 15 minutes prior to the conference call start time. A replay of the webcast will be available following the conclusion of the live call and will be accessible on the Company\u2019s website.<\/p>\n

\n About Mdxhealth<\/b>\n <\/p>\n

Mdxhealth is a leading precision diagnostics company that provides actionable molecular information to personalize patient diagnosis and treatment. The Company\u2019s tests are based on proprietary genomic, epigenetic (methylation), exosomal and other molecular technologies and assist physicians with the diagnosis and prognosis of urologic cancers and other urologic diseases. The Company\u2019s U.S. headquarters and laboratory operations are in Irvine, California, with additional laboratory operations in Waltham, Massachusetts and Plano, Texas. European headquarters are in Herstal, Belgium. For more information, visit mdxhealth.com and follow us on social media at: twitter.com\/mdxhealth, facebook.com\/mdxhealth and linkedin.com\/company\/mdxhealth.<\/p>\n

\n For more information:<\/b>
\n
\n info@mdxhealth.com<\/a>\n <\/p>\n

\n LifeSci Advisors (IR & PR)<\/b>
\n
\n John Fraunces<\/b>
\n
\n Managing Director<\/b>
\n
Tel: +1 917 355 2395
Jfraunces@lifesciadvisors.com<\/a><\/p>\n

\n Attachment<\/strong>\n <\/p>\n